LIF MED HA Haifa Obaid Sayed Immunotherapy for Glioblastoma Current Clinical Challenges and Future Directions
LIF SCI HA Haifa Obaid Sayed Simulating Multi Antigen Targeting in Glioblastoma Patients: What I Learned From Building a Dataset Introduction
DSN GEN LIF MED SCI HA Haifa Obaid Sayed Armored Tri-Antigen CAR T-Cell Therapy for Glioblastoma: A Dual-Strategy Approach to Antigen Escape… Abstract
